108 related articles for article (PubMed ID: 15566360)
1. Biosynthesis of FVIII in megakaryocytic cells: improved production and biochemical characterization.
Rodriguez MH; Plantier JL; Enjolras N; Réa M; Leboeuf M; Uzan G; Négrier C
Br J Haematol; 2004 Dec; 127(5):568-75. PubMed ID: 15566360
[TBL] [Abstract][Full Text] [Related]
2. Expression of coagulation factor IX in a haematopoietic cell line.
Rodriguez MH; Enjolras N; Plantier JL; Réa M; Leboeuf M; Uzan G; Bordet JC; Négrier C
Thromb Haemost; 2002 Mar; 87(3):366-73. PubMed ID: 11916066
[TBL] [Abstract][Full Text] [Related]
3. Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter.
Picanço V; Heinz S; Bott D; Behrmann M; Covas DT; Seifried E; Tonn T
Cytotherapy; 2007; 9(8):785-94. PubMed ID: 17917890
[TBL] [Abstract][Full Text] [Related]
4. Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cells.
Herder C; Tonn T; Oostendorp R; Becker S; Keller U; Peschel C; Grez M; Seifried E
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2266-72. PubMed ID: 14551158
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
[TBL] [Abstract][Full Text] [Related]
6. A factor VIII minigene comprising the truncated intron I of factor IX highly improves the in vitro production of factor VIII.
Plantier JL; Rodriguez MH; Enjolras N; Attali O; Négrier C
Thromb Haemost; 2001 Aug; 86(2):596-603. PubMed ID: 11522009
[TBL] [Abstract][Full Text] [Related]
7. Expression of human factor VIII under control of the platelet-specific alphaIIb promoter in megakaryocytic cell line as well as storage together with VWF.
Shi Q; Wilcox DA; Fahs SA; Kroner PA; Montgomery RR
Mol Genet Metab; 2003 May; 79(1):25-33. PubMed ID: 12765843
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
[TBL] [Abstract][Full Text] [Related]
9. Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia.
Doering CB
Methods Mol Biol; 2008; 433():203-12. PubMed ID: 18679625
[TBL] [Abstract][Full Text] [Related]
10. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ibalpha promoter: in vivo model for platelet-targeting gene therapy.
Ohmori T; Mimuro J; Takano K; Madoiwa S; Kashiwakura Y; Ishiwata A; Niimura M; Mitomo K; Tabata T; Hasegawa M; Ozawa K; Sakata Y
FASEB J; 2006 Jul; 20(9):1522-4. PubMed ID: 16723382
[TBL] [Abstract][Full Text] [Related]
11. Transgenic pigs produce functional human factor VIII in milk.
Paleyanda RK; Velander WH; Lee TK; Scandella DH; Gwazdauskas FC; Knight JW; Hoyer LW; Drohan WN; Lubon H
Nat Biotechnol; 1997 Oct; 15(10):971-5. PubMed ID: 9335047
[TBL] [Abstract][Full Text] [Related]
12. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
Liu L; Mah C; Fletcher BS
Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
14. Role of the B domain in proteolytic inactivation of activated coagulation factor VIII by activated protein C and activated factor X.
Khrenov AV; Ananyeva NM; Saenko EL
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):379-88. PubMed ID: 16788314
[TBL] [Abstract][Full Text] [Related]
15. Analysis of factor VIII mediated suppression of lentiviral vector titres.
Radcliffe PA; Sion CJ; Wilkes FJ; Custard EJ; Beard GL; Kingsman SM; Mitrophanous KA
Gene Ther; 2008 Feb; 15(4):289-97. PubMed ID: 18046428
[TBL] [Abstract][Full Text] [Related]
16. Phenotype correction of hemophilia A mice with adeno-associated virus vectors carrying the B domain-deleted canine factor VIII gene.
Ishiwata A; Mimuro J; Kashiwakura Y; Niimura M; Takano K; Ohmori T; Madoiwa S; Mizukami H; Okada T; Naka H; Yoshioka A; Ozawa K; Sakata Y
Thromb Res; 2006; 118(5):627-35. PubMed ID: 16371232
[TBL] [Abstract][Full Text] [Related]
17. An induced pluripotent stem cell-mediated and integration-free factor VIII expression system.
Yakura Y; Ishihara C; Kurosaki H; Kazuki Y; Komatsu N; Okada Y; Doi T; Takeya H; Oshimura M
Biochem Biophys Res Commun; 2013 Feb; 431(2):336-41. PubMed ID: 23291180
[TBL] [Abstract][Full Text] [Related]
18. Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy.
Ogata K; Mimuro J; Kikuchi J; Tabata T; Ueda Y; Naito M; Madoiwa S; Takano K; Hasegawa M; Ozawa K; Sakata Y
Gene Ther; 2004 Feb; 11(3):253-9. PubMed ID: 14737084
[TBL] [Abstract][Full Text] [Related]
19. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.
Chao H; Mansfield SG; Bartel RC; Hiriyanna S; Mitchell LG; Garcia-Blanco MA; Walsh CE
Nat Med; 2003 Aug; 9(8):1015-9. PubMed ID: 12847523
[TBL] [Abstract][Full Text] [Related]
20. New high-technology products for the treatment of haemophilia.
Pipe SW; Saint-Remy JM; Walsh CE
Haemophilia; 2004 Oct; 10 Suppl 4():55-63. PubMed ID: 15479373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
